Dyne Therapeutics, Inc. DYN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

47/100

2/6 Pass

SharesGrow Intrinsic Value

Dyne Therapeutics, Inc. (DYN) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は ECP ControlCo, LLC 14,291,152 株保有. その他の主要保有者には FRANKLIN RESOURCES INC および Kersten Dirk.

過去12ヶ月間にインサイダーは 40 件の取引を実施 DYN 株式 — 19 件の買い (評価額 $18.34M) および 18 件の売り (評価額 $11.68M). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.

DYN インサイダー保有状況

最大保有者

ECP ControlCo, LLC

14,291,152 株

買い（12ヶ月）

$18.34M 評価額

売り（12ヶ月）

$11.68M 評価額

12ヶ月取引活動

買い 48%

売り 45%

インサイダー上位保有者

#	氏名	役職	保有株数	最終申告日	相対規模
1	Ecp Controlco, Llc	10 Percent Owner	14,291,152	2018-01-11	100%
2	Franklin Resources Inc	10 Percent Owner	8,927,023	2015-06-03	62%
3	Kersten Dirk	Director	4,644,386	2026-03-13	32%
4	Atlas Venture Opportunity Fund Ii, L.p.	Director	934,581	2022-12-14	7%
5	Atlas Venture Fund Xi, L.p.	10 Percent Owner	903,527	2024-02-28	6%
6	Atlas Venture Opportunity Fund I, L.p.	10 Percent Owner	847,388	2024-03-05	6%
7	Flexon Robert C	President and CEO	497,281	2018-03-12	3%
8	Cox John	CEO & President	374,145	2026-03-06	3%
9	Beskrovnaya Oxana	Chief Scientific Officer	195,840	2025-03-13	1%
10	Kerr Douglas	Chief Medical Officer	171,606	2026-03-06	1%
11	Friedl-naderer Johanna	Chief Commercial Officer	154,581	2026-03-06	1%
12	Farwell Wildon	Chief Medical Officer	143,222	2024-08-20	1%
13	Mcneill Jonathan	Chief Business Officer	132,106	2024-08-20	1%
14	High Susanna Gatti	Chief Operating Officer	131,636	2024-09-19	1%
15	Subramanian Romesh	10 Percent Owner, Officer: Chief Scientific Officer	128,185	2020-09-18	1%
16	Lucera Erick	Chief Financial Officer	125,373	2026-04-03	1%
17	Scalzo Richard William	SVP, Head of Finance & Admin.	122,330	2025-03-13	1%
18	Freeland Clint	Exec. VP and CFO	94,161	2018-03-12	1%
19	James Catherine C.	Exec VP and General Counsel	84,712	2018-03-12	1%
20	Brumm Joshua T	CEO & President	83,269	2024-03-12	1%

最近の取引 (過去12ヶ月)

日付	氏名	役職	種類	株数	株価	価値
2026-04-01	Lucera Erick	Chief Financial Officer	情報に基づく売り	5,727	$18.64	$106.75K
2026-03-30	Posner Brian S	Director	情報に基づく買い	2,000	$17.08	$34.16K
2026-03-11	Kersten Dirk	Director	情報に基づく売り	129,672	$19.52	$2.53M
2026-03-11	Posner Brian S	Director	情報に基づく買い	2,000	$19.35	$38.7K
2026-03-10	Kersten Dirk	Director	情報に基づく売り	281,858	$19.80	$5.58M
2026-03-09	Kersten Dirk	Director	情報に基づく売り	177,690	$17.72	$3.15M
2026-03-06	Posner Brian S	Director	情報に基づく買い	3,000	$15.06	$45.18K
2026-03-05	Friedl-naderer Johanna	Chief Commercial Officer	情報に基づく売り	148	$14.90	$2.21K
2026-03-05	Kerr Douglas	Chief Medical Officer	情報に基づく売り	904	$14.90	$13.47K
2026-03-05	Cox John	CEO & President	情報に基づく売り	2,732	$14.90	$40.71K
2026-02-12	Friedl-naderer Johanna	Chief Commercial Officer	RSU 付与（制限付株式）	90,000	$16.00	$1.44M
2026-02-12	Kerr Douglas	Chief Medical Officer	RSU 付与（制限付株式）	130,000	$16.00	$2.08M
2026-02-12	Lucera Erick	Chief Financial Officer	RSU 付与（制限付株式）	105,000	$16.00	$1.68M
2026-02-12	Cox John	CEO & President	RSU 付与（制限付株式）	285,000	$16.00	$4.56M
2025-12-22	Karnani Vikram	Director	RSU 付与（制限付株式）	59,665	$20.78	$1.24M
2025-12-22	Karnani Vikram	Officer	不明	-	-	-
2025-12-05	Friedl-naderer Johanna	Chief Commercial Officer	情報に基づく売り	144	$20.72	$2.98K
2025-12-05	Kerr Douglas	Chief Medical Officer	情報に基づく売り	880	$20.72	$18.23K
2025-12-05	Cox John	CEO & President	情報に基づく売り	2,662	$20.72	$55.16K
2025-10-01	Posner Brian S	Director	RSU 付与（制限付株式）	70,000	$12.50	$875K
2025-10-01	Posner Brian S	Director	不明	-	-	-
2025-09-05	Cox John	CEO & President	情報に基づく売り	2,640	$13.41	$35.4K
2025-09-05	Friedl-naderer Johanna	Chief Commercial Officer	情報に基づく売り	144	$13.41	$1.93K
2025-09-04	Friedl-naderer Johanna	Chief Commercial Officer	情報に基づく売り	894	$13.27	$11.86K
2025-09-05	Kerr Douglas	Chief Medical Officer	情報に基づく売り	873	$13.41	$11.71K